Loading...
Back to narrative

EPC: Share Repurchases And Earnings Outlook Will Support Attractive Returns Through 2026

Brand Innovation And International Expansion Will Unlock Future Value

EPC logo
EPC
AnalystConsensusTarget
Not Invested
Published 11 Sep 2024

Update shared on 16 Dec 2025

Previous
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-49.3%
7D
8.2%

Analysts have nudged their price target on Edgewell Personal Care modestly higher to approximately $23.86 per share, reflecting slightly stronger expectations for revenue growth, profit margins, and future earnings multiples.

What's in the News

  • Issued fiscal 2026 earnings guidance calling for reported net sales growth of roughly 0.5% to 3.5%, with organic net sales expected to range from a 1% decline to a 2% increase, and GAAP EPS projected between $1.10 and $1.50 (company guidance)
  • Announced a new share repurchase program authorizing up to $100 million of common stock buybacks (company announcement)
  • Board of Directors approved a new share repurchase plan on November 13, 2025, which reinforces the company focus on capital returns (Board authorization)
  • Reported that under the prior buyback launched in February 2018, the company has completed the repurchase of 9,773,306 shares, or 19.2% of shares outstanding, for a total of $356.96 million, with no additional shares repurchased in the quarter ended September 30, 2025 (buyback update)

Valuation Changes

  • Fair Value: Unchanged at approximately $23.86 per share, indicating no revision to the core valuation estimate.
  • Discount Rate: Fallen slightly from about 11.35% to 11.24%, reflecting a modest reduction in perceived risk or required return.
  • Revenue Growth: Risen slightly from roughly 1.32% to 1.38%, pointing to marginally stronger long term top line expectations.
  • Net Profit Margin: Increased slightly from about 8.16% to 8.46%, signaling a small improvement in projected profitability.
  • Future P/E: Declined modestly from around 7.16x to 6.87x, suggesting a slightly lower multiple applied to forward earnings despite stable fair value.

Have other thoughts on Edgewell Personal Care?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.